Page last updated: 2024-09-05

tbc-11251 and Abnormality, Heart

tbc-11251 has been researched along with Abnormality, Heart in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Book, WM; Lee, EK; Lyle, TA; McConnell, ME; Mehta, PK; Simpson, L	1

Other Studies

1 other study(ies) available for tbc-11251 and Abnormality, Heart

Article	Year
Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects. Texas Heart Institute journal, 2008, Volume: 35, Issue:3 Topics: Administration, Oral; Adult; Antihypertensive Agents; Bosentan; Dose-Response Relationship, Drug; Drug Administration Schedule; Eisenmenger Complex; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Exercise Test; Female; Heart Defects, Congenital; Humans; Isoxazoles; Male; Middle Aged; Oxygen; Retrospective Studies; Sulfonamides; Thiophenes	2008

Article

Year

Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects.

Texas Heart Institute journal, 2008, Volume: 35, Issue:3

Topics: Administration, Oral; Adult; Antihypertensive Agents; Bosentan; Dose-Response Relationship, Drug; Drug Administration Schedule; Eisenmenger Complex; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Exercise Test; Female; Heart Defects, Congenital; Humans; Isoxazoles; Male; Middle Aged; Oxygen; Retrospective Studies; Sulfonamides; Thiophenes

2008